Structure and function of an irreversible agonist-β(2) adrenoceptor complex
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Structure and function of an irreversible agonist-β(2) adrenoceptor complex. / Rosenbaum, Daniel M; Zhang, Cheng; Lyons, Joseph A; Holl, Ralph; Aragao, David; Arlow, Daniel H; Rasmussen, Søren Gøgsig Faarup; Choi, Hee-Jung; Devree, Brian T; Sunahara, Roger K; Chae, Pil Seok; Gellman, Samuel H; Dror, Ron O; Shaw, David E; Weis, William I; Caffrey, Martin; Gmeiner, Peter; Kobilka, Brian K.
In: Nature, Vol. 469, No. 7329, 13.01.2011, p. 236-40.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Structure and function of an irreversible agonist-β(2) adrenoceptor complex
AU - Rosenbaum, Daniel M
AU - Zhang, Cheng
AU - Lyons, Joseph A
AU - Holl, Ralph
AU - Aragao, David
AU - Arlow, Daniel H
AU - Rasmussen, Søren Gøgsig Faarup
AU - Choi, Hee-Jung
AU - Devree, Brian T
AU - Sunahara, Roger K
AU - Chae, Pil Seok
AU - Gellman, Samuel H
AU - Dror, Ron O
AU - Shaw, David E
AU - Weis, William I
AU - Caffrey, Martin
AU - Gmeiner, Peter
AU - Kobilka, Brian K
PY - 2011/1/13
Y1 - 2011/1/13
N2 - G-protein-coupled receptors (GPCRs) are eukaryotic integral membrane proteins that modulate biological function by initiating cellular signalling in response to chemically diverse agonists. Despite recent progress in the structural biology of GPCRs, the molecular basis for agonist binding and allosteric modulation of these proteins is poorly understood. Structural knowledge of agonist-bound states is essential for deciphering the mechanism of receptor activation, and for structure-guided design and optimization of ligands. However, the crystallization of agonist-bound GPCRs has been hampered by modest affinities and rapid off-rates of available agonists. Using the inactive structure of the human β(2) adrenergic receptor (β(2)AR) as a guide, we designed a β(2)AR agonist that can be covalently tethered to a specific site on the receptor through a disulphide bond. The covalent β(2)AR-agonist complex forms efficiently, and is capable of activating a heterotrimeric G protein. We crystallized a covalent agonist-bound β(2)AR-T4L fusion protein in lipid bilayers through the use of the lipidic mesophase method, and determined its structure at 3.5 Å resolution. A comparison to the inactive structure and an antibody-stabilized active structure (companion paper) shows how binding events at both the extracellular and intracellular surfaces are required to stabilize an active conformation of the receptor. The structures are in agreement with long-timescale (up to 30 μs) molecular dynamics simulations showing that an agonist-bound active conformation spontaneously relaxes to an inactive-like conformation in the absence of a G protein or stabilizing antibody.
AB - G-protein-coupled receptors (GPCRs) are eukaryotic integral membrane proteins that modulate biological function by initiating cellular signalling in response to chemically diverse agonists. Despite recent progress in the structural biology of GPCRs, the molecular basis for agonist binding and allosteric modulation of these proteins is poorly understood. Structural knowledge of agonist-bound states is essential for deciphering the mechanism of receptor activation, and for structure-guided design and optimization of ligands. However, the crystallization of agonist-bound GPCRs has been hampered by modest affinities and rapid off-rates of available agonists. Using the inactive structure of the human β(2) adrenergic receptor (β(2)AR) as a guide, we designed a β(2)AR agonist that can be covalently tethered to a specific site on the receptor through a disulphide bond. The covalent β(2)AR-agonist complex forms efficiently, and is capable of activating a heterotrimeric G protein. We crystallized a covalent agonist-bound β(2)AR-T4L fusion protein in lipid bilayers through the use of the lipidic mesophase method, and determined its structure at 3.5 Å resolution. A comparison to the inactive structure and an antibody-stabilized active structure (companion paper) shows how binding events at both the extracellular and intracellular surfaces are required to stabilize an active conformation of the receptor. The structures are in agreement with long-timescale (up to 30 μs) molecular dynamics simulations showing that an agonist-bound active conformation spontaneously relaxes to an inactive-like conformation in the absence of a G protein or stabilizing antibody.
KW - Adrenergic beta-2 Receptor Agonists
KW - Crystallization
KW - Crystallography, X-Ray
KW - Disulfides
KW - Drug Inverse Agonism
KW - Heterotrimeric GTP-Binding Proteins
KW - Humans
KW - Lipid Bilayers
KW - Models, Molecular
KW - Molecular Dynamics Simulation
KW - Procaterol
KW - Propanolamines
KW - Protein Conformation
KW - Receptors, Adrenergic, beta-2
KW - Recombinant Fusion Proteins
KW - Viral Proteins
U2 - 10.1038/nature09665
DO - 10.1038/nature09665
M3 - Journal article
C2 - 21228876
VL - 469
SP - 236
EP - 240
JO - Nature
JF - Nature
SN - 0028-0836
IS - 7329
ER -
ID: 120588382